GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technologyGlaxoSmithKline (GSK) has filed a lawsuit against Pfizer and BioNTech in Delaware federal court, alleging infringement of GSK's patents rel...
Germany’s BioNTech revises plans for African vaccine factory networkIn a potential blow for Africa’s hopes of greater vaccine self-reliance, the German biotech company is currently not moving forward with a ...
Moderna sues Pfizer/BioNTech for patent infringement over COVID vaccineModerna alleges Pfizer/BioNTech, without permission, copied mRNA technology that Moderna had patented between 2010 and 2016, well before CO...
Amid Covid vaccine success, BioNTech plans to return €2bn to shareholdersAfter the success of the covid vaccine, BioNTech is planning to return €2bn to shareholders. BioNTech will continue the clinical trial to b...
Taiwan's Terry Gou, TSMC reach initial agreements for BioNTech vaccinesTaiwan's government has tried for months to buy the shots directly from Germany's BioNTech and has blamed China, which claims the self-rule...
Taiwan says China blocked deal with BioNTech for COVID-19 shotsTaiwan has millions of vaccine doses on order, from AstraZeneca Plc and Moderna Inc, but has received only slightly more than 700,000 to da...
Vaccine maker BioNTech says no need to waive patentsUgur Sahin, the chief executive of BioNTech, rejected the U.S.-backed proposal to temporarily lift some intellectual property rights for va...
BioNTech committed to deliver 1.8 billion doses of COVID-19 vaccine this yearBioNTech's first-quarter total revenues were 2.05 billion euros, up from 27.7 million a year earlier, inflated by the vaccine, and includin...
BioNTech to build mRNA manufacturing site in SingaporeThe biotech company said the Singapore production facility will have an estimated annual capacity of several hundred million doses of mRNA-...
EU throws weight behind Pfizer-BioNTech and new technologyIn a stinging rebuke to pharma giant AstraZeneca, the European Union on Wednesday announced plans to negotiate a massive contract extension...
EU seeks new contract with Pfizer/BioNTech for up to 1.8 bln vaccines from 2022: EU sourceThe EU official, who asked not to be named because the matter is confidential, said the EU executive had already decided to approach Pfizer...
BioNTech-Pfizer raise 2021 vaccine output goal to 2.5 billion dosesPfizer previously said the partners would likely produce between 2.3 billion and 2.4 billion doses in 2021. BioNTech cited its new facility...
Hong Kong halts Pfizer/BioNTech COVID-19 vaccines, investigates defective packagingThe government said it had received notice from Fosun Pharma Industrial (Hong Kong), the distributor of the Pfizer/BioNTech vaccine in the ...
Pfizer/BioNTech say COVID-19 vaccine likely to prevent asymptomatic infectionThe companies also said the latest analysis of the Israeli data shows the vaccine was 97% effective in preventing symptomatic disease, seve...
Pfizer-BioNTech say Covid vaccine works against UK, South Africa variantsWhile the findings indicated no need for a new vaccine to tackle the new strains, Pfizer and BioNTech said they would respond if there was ...
China's Fosun plans plant to make BioNTech's COVID-19 vaccine: CaixinThe first phase of the China-based manufacturing facility will have production capacity of 200 million doses, Caixin said, citing people fa...
Dubai to begin inoculations with Pfizer-BioNTech vaccine from WednesdayDubai will start inoculating people with the COVID-19 vaccine produced by Pfizer and BioNTech for free from Wednesday, the emirate's govern...